Bruce J. Dezube
- Oncology top 0.2%
- Molecular Biology top 5%
- Pathology and Forensic Medicine top 0.5%
- Epidemiology top 2%
- Infectious Diseases top 1%
- Co-authors
- Liron PantanowitzDavid M. AboulafiaGeoffrey I. ShapiroLawrence D. KaplanDonald W. NorthfeltJorge J. CastilloSusan E. KrownAntoinette R. Tan
- Topics
- Viral-associated cancers and disorders (80 papers)Lymphoma Diagnosis and Treatment (53 papers)HIV/AIDS drug development and treatment (23 papers)
- Journals
- New England Journal of MedicineProceedings of the National Academy of SciencesNature Medicine
- Partner nations
- United StatesUnited KingdomIsrael
In The Last Decade
Bruce J. Dezube
189 papers receiving 8.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Oncology 5.4k
- Molecular Biology 2.5k
- Pathology and Forensic Medicine 2.0k
- Epidemiology 1.5k
- Infectious Diseases 1.1k
Countries citing papers authored by Bruce J. Dezube
This map shows the geographic impact of Bruce J. Dezube's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bruce J. Dezube with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bruce J. Dezube more than expected).
Fields of papers citing papers by Bruce J. Dezube
This network shows the impact of papers produced by Bruce J. Dezube. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bruce J. Dezube. The network helps show where Bruce J. Dezube may publish in the future.
Co-authorship network of co-authors of Bruce J. Dezube
This figure shows the co-authorship network connecting the top 25 collaborators of Bruce J. Dezube. A scholar is included among the top collaborators of Bruce J. Dezube based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bruce J. Dezube. Bruce J. Dezube is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 162 | |
| 3 | 139 | |
| 4 | 117 | |
| 5 | 75 | |
| 6 | 197 | |
| 7 | 39 | |
| 8 | 97 | |
| 9 | Phase I trial with a novel orally administered synthetic triterpenoid RTA 402 (CDDO-Me) in patients with solid tumors and lymphoid malignancies | 4 |
| 10 | 22 | |
| 11 | Kaposi sarcoma of the larynx. | 2 |
| 12 | 99 | |
| 13 | 386 | |
| 14 | AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART. | 32 |
| 15 | 42 | |
| 16 | 485 | |
| 17 | 20 | |
| 18 | 276 | |
| 19 | 214 | |
| 20 | 51 |
About Bruce J. Dezube
Bruce J. Dezube is a scholar working on Oncology, Virology and Pathology and Forensic Medicine, having authored 196 papers that have together received 9.0k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (80 papers), Lymphoma Diagnosis and Treatment (53 papers) and HIV/AIDS drug development and treatment (23 papers). The work is most often cited by research in Oncology (5.4k citations), Virology (758 citations) and Pathology and Forensic Medicine (2.0k citations). Bruce J. Dezube has collaborated with scholars based in United States, United Kingdom and Israel. Frequent co-authors include Liron Pantanowitz, David M. Aboulafia, Geoffrey I. Shapiro, Lawrence D. Kaplan, Donald W. Northfelt, Jorge J. Castillo, Susan E. Krown, Antoinette R. Tan, Jeannette Y. Lee and Donald P. Lawrence. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.